What Are Peptides? Peptides are running your biology right now. Every meal, every hour of sleep, every time your body repairs itself, peptides are coordinating the response. They regulate hunger, direct immune activity, trigger tissue repair, and control dozens of processes you never think about.
In 2026, they’re behind the weight loss drugs reshaping medicine, the skin compounds entering clinical trials, and the longevity research drawing billions in investment. If you’re new to this space, the Beginner Guide to Research Peptides is a good place to start. For context on where the field is heading, see Why Peptide Research Is Growing Worldwide.
Key Research Facts: What Are Peptides
- Ozempic, Wegovy, and Mounjaro are all peptides, synthetic versions of molecules your body already produces
- Peptides are not supplements, not steroids, and not traditional drugs, they work through a fundamentally different mechanism
- Over 7,000 naturally occurring peptides have been identified in human biology The FDA approved 26 peptide-based drugs in a single six-year window, more than any prior period in history
- Big Pharma invested over $42 billion into peptide therapeutics in 2023 alone
- Research peptides are lab-produced compounds studied under a Research Use Only framework, not approved for human use
- Long-term effects of many synthetic peptides remain understudied, and researchers continue to flag gaps in the safety data
Why Peptides Are Having a Moment Right Now
Ozempic launched in 2017. By 2023 it was the most talked about drug on the planet. By 2024, its manufacturer Novo Nordisk briefly became the most valuable company in Europe. None of that happened because of a marketing campaign. It happened because a peptide, a synthetic version of a molecule your gut already produces, turned out to have effects on hunger, metabolism, and body weight that no prior drug had achieved at that scale.
That’s the moment peptide research is in right now. Not because the science is new, researchers have studied peptide signaling for decades — but because the tools to synthesize, stabilize, and study these compounds have finally caught up with the biology. What was once expensive and inconsistent to produce can now be manufactured at scale, with documented purity, and studied across a range of biological systems.
The pharmaceutical industry noticed. Global investment in peptide therapeutics exceeded $42 billion in 2023. Over 80 peptide-based drugs are approved globally, with hundreds more in clinical development across metabolic disease, oncology, neurology, and regenerative medicine. The FDA approved 26 peptide-based drugs in a single six-year window — more than any comparable period in history.
At the same time, questions are accumulating. Long-term safety data on many synthetic peptides remains limited. Regulatory frameworks are shifting. Several compounds that were widely studied just two years ago have been reclassified or restricted. The science is accelerating faster than the oversight, which is exactly why understanding what peptides actually are and how they work matters more now than it ever has. For a deeper look at where the field is heading, see Why Peptide Research Is Growing Worldwide.
What Makes Peptides Different From Everything Else
People try to place peptides in a category they already know. Supplements. Steroids. Drugs. The honest answer is none of the above, and the distinction matters because each of those categories works through a fundamentally different mechanism.
Supplements provide raw materials, vitamins, minerals, amino acids, that the body uses to run its existing processes. Peptides don’t provide materials. They deliver instructions. A peptide tells a specific receptor to activate a specific pathway. That’s a different mechanism entirely, which is why peptides are studied as research compounds rather than sold as dietary supplements. The full breakdown is in Peptides vs Supplements.
Steroids bind to androgen receptors broadly and drive widespread hormonal effects across multiple systems simultaneously. That’s both why they work and why they produce the side effects they’re known for. Peptides operate through specific receptor interactions with targeted downstream effects. The research profiles and regulatory frameworks are completely different. See Peptides vs Steroids for the detailed comparison.
Traditional pharmaceutical drugs are small molecules engineered to interact with biological targets. Peptides are sequences of amino acids that mimic or modify what the body already produces. They’re biodegradable, breaking down into amino acids rather than accumulating as foreign chemical compounds. And they’re specific in a way small molecules typically aren’t. That combination of biological origin, target specificity, and degradability is what makes them scientifically interesting, and what separates them structurally from proteins. See Peptides vs Proteins for how those two differ.
The Side Effects Question, What Research Does and Doesn't Show
The most searched question about peptides after “what are they” is some version of “are they safe.” It’s a fair question, and the honest answer is more complicated than most sources will tell you.
For peptides with decades of study behind them, the research picture is relatively established. GLP-1 receptor agonists like semaglutide have extensive clinical trial data covering cardiovascular outcomes, gastrointestinal effects, and long term metabolic changes across large patient populations. Known side effects, including nausea, vomiting, delayed gastric emptying, and in some cases muscle loss alongside fat loss, are documented and understood well enough to be weighed against benefits in a research context.
For many other synthetic peptides, the data is thinner. Compounds like BPC-157 and TB-500 have significant animal model research behind them but limited human trial data. The gap between what rat studies show and what happens in human biology is not trivial. Researchers continue to flag it. What works in a rodent model doesn’t always translate, and the mechanisms that make a compound effective can also be the mechanisms that produce unexpected effects at higher exposures or over longer timeframes.
The unknowns are the more important part of the conversation. Many synthetic peptides currently being studied have no long term safety data because they haven’t been studied long enough. That’s not a reason to dismiss the research, it’s a reason to understand the framework it’s conducted in. For a detailed look at how safety is assessed in peptide research settings, see Are Peptides Safe.
How Peptides Are Classified in Research
Not all peptides are studied the same way, and understanding how they’re classified helps make sense of why different compounds show up in different research contexts.
The most basic classification is by origin. Endogenous peptides are produced naturally by the body, insulin, GLP-1, oxytocin. Exogenous peptides are introduced from outside, either as exact synthetic copies of naturally occurring sequences or as modified analogs engineered for specific research properties. Most research peptides fall into the second category. They start with a naturally occurring sequence and modify it to improve stability, extend half life, or change receptor affinity in ways the native compound doesn’t have.
Peptides are also classified by function, metabolic peptides, immune modulating peptides, tissue repair peptides, neuropeptides. These functional categories map roughly to the research clusters that have developed around them, which is why GLP-1 analogs, growth hormone secretagogues, and regenerative compounds like BPC-157 each have distinct research communities studying them through different methodologies.
In a regulatory context, classification determines how a compound can be manufactured, distributed, and used. Research peptides operate under a Research Use Only designation, distinct from pharmaceutical drugs, distinct from dietary supplements, and subject to a regulatory framework that has been shifting significantly since 2024. How peptides are formally studied across these classifications is covered in How Peptides Are Studied in Scientific Research. How they move through biological systems once introduced is in How Peptides Move Through the Body.
Research Peptides, What They Are and How They're Sourced
Research grade peptides are synthetic compounds produced to documented purity standards, verified by third party analytical testing, and supplied under a Research Use Only framework. They’re not pharmaceutical drugs. They’re not dietary supplements. They’re tools for studying how peptide signaling works in controlled laboratory settings.
The dominant production method is solid phase peptide synthesis, a process that builds the amino acid chain one residue at a time on a solid resin support. This allows precise sequence control and batch to batch consistency that biological extraction can’t match. Purity is verified through high performance liquid chromatography and mass spectrometry, and documented in a certificate of analysis that should accompany every research grade compound. How that synthesis process works and what distinguishes natural from synthetic sequences is covered in How Peptides Are Created: Natural vs Synthetic.
The Research Use Only designation matters. It means these compounds are supplied strictly for laboratory research, not for human consumption, not as clinical treatments, not as supplements. The regulatory framework governing how they can be manufactured and distributed has changed significantly in 2025 and 2026, and researchers sourcing these compounds need to understand what that framework requires. The full explanation is in Research Use Only Explained.
BioStrata supplies research grade peptides across the compounds most active in current research, each with full third party COA documentation. BPC-157 is among the most studied regenerative peptides in the current research landscape. The full catalog is available at the BioStrata shop.
FAQs — What Are Peptides?
Are peptides the same as proteins?
Related but not the same. Both are built from amino acid chains. Peptides are short, typically under 50 amino acids. Proteins are longer chains that fold into complex three dimensional structures essential to their function. A peptide is specific and targeted in its signaling. A protein like collagen or hemoglobin is a large structural or functional component. The line isn’t always sharp, but the functional distinction is what matters for research.
Does my body already make peptides?
Yes, constantly. Over 7,000 naturally occurring peptides have been identified in human biology. Every time you eat, sleep, exercise, or experience stress, peptides are being produced and cleared as part of the biological response. Insulin, GLP-1, oxytocin, and growth hormone releasing peptides are all examples. Synthetic research peptides are lab-produced versions of these naturally occurring sequences, sometimes exact copies, sometimes modified analogs engineered for specific research properties. See Are Peptides Natural for the full breakdown.
Are research peptides safe?
Research peptides are supplied under a Research Use Only framework and are not approved for human consumption. Safety evaluation in a research context looks at compound purity, storage stability, and handling protocols. For many synthetic peptides, long term human safety data remains limited. The research landscape on this is covered in Are Peptides Safe.
What’s the difference between a research peptide and a pharmaceutical drug?
Pharmaceutical drugs go through clinical trials, receive FDA approval, and are prescribed for specific medical conditions. Research peptides are studied in laboratory settings under a Research Use Only designation. Some research peptides are analogs of compounds that have gone through the pharmaceutical pathway, but the research grade compound itself is not a drug and is not approved for therapeutic use.
How long do peptides take to work in research settings?
It depends entirely on the compound, the biological system being studied, and the endpoint being measured. Some peptides produce observable effects in hours. Others require sustained exposure over weeks before measurable changes appear. The timeline question is covered in detail in How Long Do Peptides Take to Work.
- CONTINUE LEARNING
Explore Related Peptide Topics
Continue building your understanding by exploring related foundational peptide topics.
References & Sources
- Peptide Biochemistry: Structure, Function, and Classification — StatPearls / NCBI Bookshelf (2023)
- Peptide Therapeutics: Current Status and Future Directions — Drug Discovery Today (2015)
- Peptides as Therapeutic Agents: Challenges and Opportunities — Molecules (2023)
- Peptide-Based Drug Development: Delivery Platforms, Therapeutics, and Vaccines — Signal Transduction and Targeted Therapy (2025)
Disclaimer: BioStrata Research provides materials for laboratory research use only. The information in this article is intended strictly for educational and informational purposes within a research context and should not be interpreted as medical advice, treatment guidance, or product claims for human use.